|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
31 August 2015 |
|
Main ID: |
NCT02532348 |
|
Date of registration:
|
20/08/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV Infection
PLAQUETTE |
|
Scientific title:
|
Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV Infection |
|
Date of first enrolment:
|
August 2011 |
|
Target sample size:
|
133 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02532348 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Frédéric Lucht, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
CHU Saint-Etienne |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Unchanged antiretroviral therapy for at least one year
- Plasmatic viral load < 40 copies/ml.
- signature of informed consent
Exclusion Criteria:
- Hepatitis B Virus (HBV) and/or Hepatitis C Virus (HVC) coinfection
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Human Immunodeficiency Virus
|
|
Intervention(s)
|
|
Other: Blood samples
|
|
Primary Outcome(s)
|
|
Plasmatic level of sCD40L
[Time Frame: day 1]
|
|
Secondary Outcome(s)
|
|
sCD40L level
[Time Frame: day 1]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|